Showing 1451-1460 of 3082 results for "".
- Teens with Epilepsy Are More Likely to Discuss Suicide Onlinehttps://practicalneurology.com/news/teens-with-epilepsy-are-more-likely-to-discuss-suicide-online/2469098/Results of a study presented at the American Epilepsy Society Annual Meeting December 6-10, 2019 in Baltimore, MD show that teens with epilepsy are more than twice as likely as adults with the condition to talk about suicide online. The data suggests that teens are concerned with the unknown aspe
- Women with Epilepsy Are Less Likely to Breastfeed Their Newbornshttps://practicalneurology.com/news/women-with-epilepsy-are-less-likely-to-breastfeed-their-newborns/2469096/Findings from 2 clinical studies presented at the American Epilepsy Society Annual Meeting, December 6-10 in Baltimore, MD show that women with epilepsy are less likely to breastfeed their newborns than new mothers without epilepsy. Support from neurologists and lactation consultants, however, ca
- Database of Eye-Tracking Movements Could Aid Diagnosis and Treatmenthttps://practicalneurology.com/news/database-of-eye-tracking-movements-could-aid-diagnosis-and-treatment/2468784/Eye-tracking technology (Brain Health EyeQ; RightEye, Bethesda, MD) that captures data on people’s eye movements has been used to produce a database of 1 billion data points from 100,000 individuals. Data includes eye tracking measures of alignment, object tracking, depth perception, and dy
- FDA Provides Expanded Clearance for Device to Treat Migraine in Childrenhttps://practicalneurology.com/news/fda-provides-expanded-clearance-for-device-to-treat-migraine-in-children/2468822/The Food and Drug Administration (FDA) has granted new marketing clearance for a device that provides acute and preventive treatment of migraine to include children 12 years of age and older. The technology (sTMS; eNeura, Inc., Baltimore, MD) is a non-invasive device that uses single-puls
- Studies at MDA 2026 Evaluate High-Dose Spinraza for Spinal Muscular Atrophyhttps://practicalneurology.com/news/in-spinal-muscular-atrophy-high-dose-spinraza-improved-functional-and-survival-outcomes-vs-standard-regimen/2486096/
- Explanation for the New Brunswick Mystery Illness Proposed in New Articlehttps://practicalneurology.com/news/explanation-for-the-new-brunswick-mystery-illness-proposed-in-new-article/2474615/The cluster of cases initially identified as the New Brunswick neurological syndrome of unknown cause (NSUC) and thought to constitute a novel neurologic disorder is likely to be a combination of well-known and misdiagnosed disorders, according to results of a cross-sectional study published in J
- Missed Diagnostic Opportunities Common Among Patients With Pregnancy-Associated Strokehttps://practicalneurology.com/news/missed-diagnostic-opportunities-found-to-be-common-among-patients-with-pregnancy-associated-stroke/2485649/More than 1 in 4 pregnant or postpartum individuals with acute stroke experienced a missed diagnostic opportunity (MDO), according to a retrospective multicenter study published in Stroke. The findings highlight frequent diagnostic delays, which according to the study authors, suggest th
- New Guidelines Issued for Gene Therapy Treatment in Duchenne Muscular Dystrophyhttps://practicalneurology.com/news/new-guidelines-issued-for-gene-therapy-treatment-in-duchenne-muscular-dystrophy/2483121/The Muscular Dystrophy Association (MDA) and Parent Project Muscular Dystrophy (PPMD) have jointly published consensus guidelines on the safe and equitable administration of gene therapy for Duchenne muscular dystrophy (DMD) in Neuromuscular Disorders. The recommendations provide neurolo
- Diagnosis and Care Recommendations for Limb-Girdle Muscle Dystrophy 2I/R9 Presentedhttps://practicalneurology.com/news/diagnosis-and-care-recommendations-for-limb-girdle-muscle-dystrophy-2ir9-presented/2473813/Draft standard of care (SoC) guidelines for the diagnosis and management of people with limb-girdle muscle dystrophy 2I/R9 (LGMDR9) were presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. According to the presenters of the draft SoC, the guidelines ar
- Over $500,000 Awarded for ALS and Mitochondrial Myopathies Researchhttps://practicalneurology.com/news/over-500000-awarded-for-als-and-mitochondrial-myopathies-research/2470938/The Muscular Dystrophy Association (MDA; Chicago, IL) has partnered with the French Muscular Dystrophy Association (AFM-Téléthon; Evry, France) to award a total of $510,000 in grant funding across 2 research projects. The grant funding is intended to accelerate the development of tr